NCT00098800
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +19 more
- Locations
-
- Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
Clinical trial condition
Carcinoma, Ovarian Epithelial
Explore clinical trials studying Carcinoma, Ovarian Epithelial. Study availability and eligibility vary by location and protocol.
532 public trials
64 recruiting studies
Carcinoma, Ovarian Epithelial trial results
NCT00002901
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +54 more
- Locations
-
- Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
Completed
Women Surviving Ovarian Cancer
NCT00596349
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00490711
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bratislava, Slovakia
Active, Not Recruiting
Study of INCB123667 in Subjects With Advanced Solid Tumors
NCT05238922
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +23 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope-Lennar Foundation Cancer Center Irvine, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- Rocky Mountain Cancer Centers-Sky Ridge Lone Tree, Colorado, United States
Active, Not Recruiting
First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients
NCT06121401
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +16 more
- Locations
-
- Azienda Socio Sanitaria Territoriale (ASST) Lariana San Fermo della Battaglia, Como, Italy
- Spedali Civili Brescia, Italy
- Policlinico Careggi Florence, Italy
- Ospedale Manzoni Lecco, Italy
Active, Not Recruiting
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
NCT03872947
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- AOA-HOPE Tucson, Arizona, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- HOAG Memorial Hospital Presbyterian Newport, California, United States
Active, Not Recruiting
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
NCT02644369
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +33 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, Not Recruiting
Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC
NCT07341100
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangdong, Guangzhou, China
Active, Not Recruiting
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
NCT05200559
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States